ELI LILLY & Co SEC filings LLY
ELI LILLY & Co has 1,001 filings in SEC EDGAR's recent list, going back to Feb 3, 2022. Its latest annual report, Form 10-K, was filed on Feb 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 11-K | Employee savings plan report | Jun 23, 2026 | Dec 31, 2025 |
| 25-NSE | Delisting notice | Jun 2, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | May 11, 2026 | — |
| PX14A6G | Filing | Apr 29, 2026 | — |
| DFAN14A | Filing | Mar 31, 2026 | — |
| SC TO-T/A | Filing | Dec 9, 2025 | — |
| SC TO-T | Filing | Nov 7, 2025 | — |
| SC TO-C | Filing | Oct 24, 2025 | — |
| SC TO-T/A | Filing | Jul 24, 2025 | — |
| SC TO-T/A | Filing | Jul 22, 2025 | — |
| SC TO-T/A | Filing | Jul 15, 2025 | — |
| SC TO-T | Filing | Jun 25, 2025 | — |
| 11-K | Employee savings plan report | Jun 20, 2025 | Dec 31, 2024 |
| SC TO-C | Filing | Jun 17, 2025 | — |
| 25-NSE | Delisting notice | Jun 2, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | May 9, 2025 | — |
| PX14A6G | Filing | Mar 31, 2025 | — |
| SC TO-T/A | Filing | Aug 16, 2024 | — |
| SC TO-T/A | Filing | Aug 5, 2024 | — |
| SC TO-T/A | Filing | Aug 1, 2024 | — |
| SC TO-T | Filing | Jul 19, 2024 | — |
| SC TO-C | Filing | Jul 8, 2024 | — |
| 11-K | Employee savings plan report | Jun 24, 2024 | Dec 31, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 3, 2024 | — |
| PX14A6G | Filing | Apr 11, 2024 | — |
| PX14A6G | Filing | Apr 4, 2024 | — |
| PX14A6G | Filing | Mar 28, 2024 | — |
| PX14A6G | Filing | Mar 28, 2024 | — |
| PX14A6G | Filing | Mar 28, 2024 | — |
| SC TO-T/A | Filing | Dec 26, 2023 | — |
| SC TO-T/A | Filing | Dec 18, 2023 | — |
| SC TO-T/A | Filing | Dec 4, 2023 | — |
| SC TO-T/A | Filing | Nov 17, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2023 | — |
| SC TO-T/A | Filing | Nov 15, 2023 | — |
| CORRESP | Letter to the SEC | Nov 9, 2023 | — |
| SC TO-T/A | Filing | Nov 8, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2023 | — |
| SC TO-T/A | Filing | Oct 27, 2023 | — |
| CORRESP | Letter to the SEC | Oct 26, 2023 | — |
| SC TO-T | Filing | Oct 13, 2023 | — |
| CORRESP | Letter to the SEC | Oct 5, 2023 | — |
| SC TO-C | Filing | Oct 3, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2023 | — |
| CORRESP | Letter to the SEC | Sep 20, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2023 | — |
| SC TO-T/A | Filing | Aug 10, 2023 | — |
| SC TO-T/A | Filing | Aug 9, 2023 | — |
| SC TO-T/A | Filing | Aug 1, 2023 | — |
| SC TO-T/A | Filing | Jul 25, 2023 | — |
| SC TO-T/A | Filing | Jul 18, 2023 | — |
| SC TO-T/A | Filing | Jul 17, 2023 | — |
| SC TO-T | Filing | Jul 13, 2023 | — |
| SC TO-T | Filing | Jun 30, 2023 | — |
| SC TO-C | Tender offer statement | Jun 29, 2023 | — |
| 11-K | Employee savings plan report | Jun 22, 2023 | Dec 31, 2022 |
| SC TO-C | Filing | Jun 20, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 5, 2023 | — |
| PX14A6G | Filing | Apr 21, 2023 | — |
| PX14A6G | Filing | Apr 10, 2023 | — |
| PX14A6G | Filing | Apr 4, 2023 | — |
| PX14A6G | Filing | Mar 24, 2023 | — |
| PX14A6G | Filing | Mar 22, 2023 | — |
| SC TO-T/A | Filing | Nov 30, 2022 | — |
| SC TO-T/A | Filing | Nov 28, 2022 | — |
| SC TO-T/A | Filing | Nov 14, 2022 | — |
| SC TO-T | Filing | Oct 31, 2022 | — |
| SC TO-C | Filing | Oct 18, 2022 | — |
| 11-K | Employee savings plan report | Jun 27, 2022 | Dec 31, 2021 |
| SD | Specialized disclosure (conflict minerals) | May 6, 2022 | — |
| PX14A6G | Filing | Apr 12, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2022 | — |
| CORRESP | Letter to the SEC | Apr 7, 2022 | — |
| PX14A6G | Filing | Mar 31, 2022 | — |
| PX14A6G | Filing | Mar 30, 2022 | — |
| PX14A6G | Filing | Mar 22, 2022 | — |
| PX14A6G | Filing | Mar 22, 2022 | — |
| 25-NSE | Delisting notice | Mar 2, 2022 | — |
Showing 78 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LLY (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- IN
- Headquarters
- Indianapolis, IN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 59478
- Former names
- LILLY ELI & CO (until Oct 25, 2019); LILLY ELI & CO ET AL (until Oct 14, 1994)
Other Pharmaceutical Preparations companies
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.